[1]齐弘炜,袁彪.中国常用动脉化冠状动脉旁路移植术的通畅率及疗效[J].心血管病学进展,2015,(5):559-563.[doi:10.3969/j.issn.1004-3934.2015.05.009]
 QI Hongwei,YUAN Biao.Effects and Patency of Coronary Artery Bypass Grafting Used in China[J].Advances in Cardiovascular Diseases,2015,(5):559-563.[doi:10.3969/j.issn.1004-3934.2015.05.009]
点击复制

中国常用动脉化冠状动脉旁路移植术的通畅率及疗效()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2015年5期
页码:
559-563
栏目:
综述
出版日期:
2016-05-20

文章信息/Info

Title:
Effects and Patency of Coronary Artery Bypass Grafting Used in China
作者:
齐弘炜袁彪
首都医科大学附属北京同仁医院心血管疾病诊疗中心,北京 100730
Author(s):
QI HongweiYUAN Biao
Cardiovascular Center,Beijing Tongren Hospital,Capital Medical University,Beijing 100730,China
关键词:
冠状动脉旁路移植术 全动脉化 通畅率 疗效
Keywords:
coronary artery bypass grafting complete arterial revascularization angiographic patency outcome
分类号:
R654.2
DOI:
10.3969/j.issn.1004-3934.2015.05.009
文献标志码:
A
摘要:
目前冠状动脉旁路移植术通常采用一支乳内动脉加一支或多支大隐静脉作为桥血管,大隐静脉会逐渐粥样硬化而闭塞,动脉的通畅率远高于大隐静脉。左乳内动脉已常规应用于冠状动脉旁路移植术,同应用双侧乳内动脉相比,左乳内动脉加大隐静脉被认为是远期死亡、心脏事件的独立危险因素。乳内动脉用于左侧冠状动脉时通畅率一样; 原位或复合桥移植时所有的乳内动脉通畅率相同,但吻合于主动脉时通畅率降低,所以原位乳内动脉通畅率高于游离乳内动脉。胃网膜右动脉和桡动脉宜吻合于近端狭窄严重者。双侧乳内动脉+胃网膜右动脉可避免触及主动脉,最大程度地
Abstract:
One internal-mammary-artery(IMA)and one or more saphenous vein(SV)were commonly used in coronary artery bypass grafting. However, SV will occlude with progressive atherosclerosis. The expansion of obstructions(patency)of arterial grafts was much better than saphenous vein grafts(SVG). Left IMA(LIMA)was routinely used in coronary artery bypass grafting. However in comparison with group bilateral IMA(BIMA), LIMA+SV(s)was an independent risk factor from lower chances of cardiac death, acute myocardial infarction, acute myocardial infarction in a grafted area and cardiac events. Both IMA have similar patency when used on left-sided coronaries and as in-situ or composite grafts, but have inferior patency if anastomosed to aorta. Therefore the patency of IMA in-situ was superior than the free IMA. Right gastroepiploic artery and radial artery was suitable anastomose to the coronary artery with severe proximal stenosis. BIMA with right gastroepiploic artery could decrease the central nervous system complications as far as possible because of it does not touch the aorta. When a patient undergoes their first coronary surgery and is younger than 70 years, BIMA grafting should not be denied, especially if their life expectancy is higher than 5 years. Complete arterial revascularization may be reasonable for patients less than or equal to 60 years of age with few or no co-morbidities.

参考文献/References:

[1] Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events[J]. N Engl J Med,1986,314(1):1-6.
[2] Ennker JC, Ennker IC.Coronary artery surgery: now and in the next decade[J]. HSR Proc Intensive Care Cardiovasc Anesth,2012,4(4):217-223.
[3] Taggart DP, Altman DG, Gray AM, et al.Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial(ART)[J]. Eur Heart J,2010,31(20):2470-2481.
[4] Hayward PA, Buxton BF. Contemporary coronary graft patency:5-year observational data from a randomized trial of conduits[J]. Ann Thorac Surg, 2007,84(3):795-799.
[5] Kurlansky PA, Traad EA, Dorman MJ, et al. Location of the second internal mammary artery graft does not influence outcome of coronary artery bypass grafting[J]. Ann Thorac Surg,2011,91(5):1378-1383; discussion 1383-1384.
[6] Calafiore AM, di Giammarco G, Teodori G, et al. Late results of first myocardial revascularization in multiple vessel disease: single versus bilateral intenal mammary artery with or without saphenous vein grafts[J]. Eur J Cardiothorac Surg, 2004,26(3):542-548.
[7] Weiss AJ, Zhao S, Tian DH, et al. A meta-analysis comparing bilateral internal mammary artery with left internal mammary artery for coronary artery bypass grafting[J]. Ann Cardiothorac Surg,2013,2(4):390-400.
[8] Yi G, Shine B, Rehman SM, et al. Effect of bilateral internal mammary artery grafts on long-term survival.A meta-analysis approach[J]. Circulation,2014,130(7):539-545.
[9] Benedetto U, Raja SG, Albanese A, et al. Searching for the second best graft for coronary artery bypass surgery:a network meta-analysis of randomized controlled trials[J]. Eur J Cardiothorac Surg,2015,47(1):59-65.
[10] Zhu YY, Hayward PA, Hadinata IE, et al. Long-term impact of radial artery harvest on forearm function and symptoms:a comparison with leg vein[J]. J Thorac Cardiovasc Surg,2013,145(2):412-419.
[11] Borger MA, Cohen G, Buth KJ, et al. Multiple arterial grafts. Radial versus right internal thoracic arteries[J]. Circulation,1998,98(19 Supp l):Ⅱ7-14.
[12] Caputo M, Reeves B, Marchetto G, et al. Radial versus right internal thoracic artery as a second arterial conduit for coronary surgery:early and midterm outcomes[J]. J Thorac Cardiovasc Surg,2003,126(1):39-47.
[13] Navia D, Vrancic M, Piccinini F, et al. Is the second internal thoracic artery better than the radial artery in total arterial off-pump coronary artery bypass grafting? A propensity score-matched follow-up study[J]. J Thorac Cardiovasc Surg, 2014,147(2):632-638.
[14] Hayward PA, Hare DL, Gordon I, et al. Which arterial conduit? Radial artery versus free right internal thoracic artery:six-year clinical results of a randomized controlled trial[J]. Ann Thorac Surg, 2007,84(2):493-497,discussion 497.
[15] Hayward PA, Hare DL, Gordon I, et al. Effect of radial artery or saphenous vein conduit for the second graft on 6-year clinical outcome after coronary artery bypass grafting. Results of a randomised trial[J]. Eur J Cardiothorac Surg, 2008,34(1):113-117.
[16] Desai ND, Cohen EA, Naylor CD, et al. A randomized comparison of radial artery and saphenous vein coronary bypass grafts[J]. N Engl J Med, 2004,351(22):2302-2309.
[17] Goldman S, Sethi GK, Holman W, et al. Radial artery grafts vs saphenous vein grafts in coronary artery bypass surgery:a randomized trial[J]. JAMA,2011,305(2): 167-174.
[18] Buxton BF, Raman JS, Ruengsakulrach P, et al. Radial artery patency and clinical outcomes: five year interim results of a randomized trial[J]. J Thorac Cardiovasc Surg, 2003,125(6):1363-1371.
[19] Hayward PA, Gordon IR, Hare DL, et al. Comparable patencies of the radial artery and right internal thoracic artery or saphenous vein beyond 5 years:results from the Radial Artery Patency and Clinical Outcomes trial[J]. J Thorac Cardiovasc Surg, 2010,139(1):60-65,discussion 65-67.
[20] Deb S, Cohen EA, Singh SK, et al. Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery:results from RAPS(Radial Artery Patency Study)[J]. J Am Coll Cardiol,2012,60(1):28-35.
[21] Collins P, Webb CM, Chong CF, et al. Radial artery versus saphenous vein patency randomized trial:five-year angiographic follow-up[J]. Circulation,2008,117(22):2859-2864.
[22] Cao C, Ang SC, Wolak K, et al.A meta-analysis of randomized controlled trials on mid-term angiographic outcomes for radial artery versus saphenous vein in coronary artery bypass graft surgery[J]. Ann Cardiothorac Surg,2013,2(4):401-407.
[23] Desai ND, Naylor CD, Kiss A, et al.Impact of patient and target-vessel characteristics on arterial and venous bypass graft patency:insight from a randomized trial[J]. Circulation,2007,115(6):684-691.
[24] Suma H, Tanabe H, Takahashi A, et al. Twenty years experience with the gastroepiploic artery graft for CABG[J]. Circulation,2007,116(11 Suppl):188-191.
[25] Hashimoto H, Isshiki T, Ikari Y, et al. Effects of competitive blood flow on arterial graft patency and diameter. Medium-term postoperative follow-up[J]. J Thorac Cardiovasc Surg,1996,111(2):399-407.
[26] Shimizu T, Suesada H, Cho M, et al. Flow capacity of gastroepiploic artery versus vein grafts for intermediate coronary artery stenosis[J]. Ann Thorac Surg,2005, 80(1):124-130.
[27] Eda T, Matsuura A, Miyahara K, et al. Transplantation of the free gastroepiploic artery graft for myocardial revascularization:long-term clinical and angiographic results[J]. Ann Thorac Surg,2008,85(3):880-884.
[28] Suma H, Tanabe H, Yamada J, et al. Midterm results for use of the skeletonized artery graft in coronary artery bypass[J]. Circ J,2007,71(10):1503-1505.
[29] Ali E, Saso S, Ashrafian H, et al. Does a skeletonized or pedicled right gastro-epiploic artery improve patency when used as a conduit in coronary artery bypass graft surgery? [J]. Interact Cardiovasc Thorac Surg,2010,10(2):293-298.
[30] Kim KB, Cho KR, Choi JS, et al. Right gastroepiploic artery for revascularization of the right coronary territory in off-pump total arterial revascularization: strategies to improve patency[J]. Ann Thorac Surg,2006,81(6):2135-2141.
[31] Hirose H, Amano A, Takanashi S, et al. Coronary artery bypass grafting using the gastroepiploic artery in 1 000 patients[J]. Ann Thorac Surg,2002,73(5):1371-1379.
[32] Tavilla G, Kappetein AP, Braun J,et al. Long-term follow-up of coronary artery bypass grafting in three-vessel disease using exclusively pedicled bilateral internal thoracic and right gastroepiploic arteries[J]. Ann Thorac Surg,2004,77(3):794-799.
[33] Esaki J, Koshiji T, Okamoto M, et al. Gastroepiploic artery grafting does not improve the late outcome in patients with bilateral internal thoracic artery grafting[J]. Ann Thorac Surg,2007,83(3):1024-1029.
[34] Zhu YY, Hayward PA, Hare DL, et al. Lipid management in high risk coronary patients:how effective are we at secondary intervention?[J]. Heart Lung Circ, 2012,21(2):82-87.
[35] 杭钧彪,孔烨,周健,等.全动脉化非体外循环下冠状动脉旁路移植66例分析[J].南方医科大学学报,2010,30(10):2411-2412.
[36] Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology(ESC)and the European Association for Cardio-Thoracic Surgery(EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions(EAPCI)[J]. Eur J Cardiothorac Surg,2014,46(4):517-592.
[37] Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines[J]. Circulation,2011,124: e652-e735.

相似文献/References:

[1]马琛 陈少敏 崔鸣.冠状动脉慢性完全闭塞病变治疗研究进展[J].心血管病学进展,2020,(4):333.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.001]
 MA Chen,CHEN Shaomin,CUI Ming.Treatment in Patients with Coronary Chronic Total Occlusion[J].Advances in Cardiovascular Diseases,2020,(5):333.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.001]
[2]奚云萍 臧雁翔 李为民.临床SYNTAX计分及其衍生计分在冠心病血运重建预后中的应用价值[J].心血管病学进展,2020,(5):452.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.004]
 XI Yunping,ZANG Yanxiang,LI Weimin.Value of Clinical SYNTAX Score and Its Derivative Score in Prognosis of Coronary Artery Disease with Revascularization[J].Advances in Cardiovascular Diseases,2020,(5):452.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.004]
[3]孙一博 孙莉萍 董建增.血管炎的冠状动脉风险及手术治疗进展[J].心血管病学进展,2020,(8):821.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.010]
 SUN YiboSUN LipingDONG Jianzeng.Coronary Risk and Progress in Surgical Therapy of Vasculitis[J].Advances in Cardiovascular Diseases,2020,(5):821.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.010]
[4]程悦 孟维鑫 康凯.被动选择还是主动获取?——谈“No-Touch”大隐静脉获取术的产生及研究进展[J].心血管病学进展,2020,(9):934.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.012]
 CHENG Yue,MENG Weixin,KANG Kai.Passive Selection or Active Accessthe Emergence and Research Progress of "No-touch" Technique for Great Saphenous Vein Graft[J].Advances in Cardiovascular Diseases,2020,(5):934.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.012]
[5]马浩 张世成 宋仰午 黄思源 赵栋 凤玮.单纯冠状动脉旁路移植术治疗左心室室壁瘤的回顾性队列研究[J].心血管病学进展,2023,(5):465.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.019]
 MA Hao,ZHANG Shicheng,SONG Yangwu,et al.Surgical Effects of Coronary Artery Bypass Grafting Alone for Patients with Left Ventricular Aneurysm:A Retrospective Cohort Study[J].Advances in Cardiovascular Diseases,2023,(5):465.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.019]
[6]赵沐华 周帆 穆军升.冠状动脉旁路移植术后高敏心肌肌钙蛋白水平与预后危险因素评估价值的临床研究进展[J].心血管病学进展,2024,(11):989.[doi:10.16806/j.cnki.issn.1004-3934.2024.11.007]
 ZHAO Muhua,ZHOU Fan,MU Junsheng.Evaluation Value of High-Sensitivity Troponin Levels and Prognostic Risk Factors After Coronary Artery Bypass Grafting[J].Advances in Cardiovascular Diseases,2024,(5):989.[doi:10.16806/j.cnki.issn.1004-3934.2024.11.007]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81370237) 作者简介:齐弘炜(1970—),副主任医师,博士,主要从事心外科相关临床研究。Email: qiheart@sohu.com
更新日期/Last Update: 2016-05-20